Healthy Clinical Trial
— PRMRP-NormsOfficial title:
Iterative Design of Custom Dynamic Orthoses and Comprehensive Design of Musculoskeletal Model
NCT number | NCT04800510 |
Other study ID # | 202002131 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 21, 2021 |
Est. completion date | June 25, 2022 |
Verified date | December 2023 |
Source | University of Iowa |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The proposed study evaluates the effect of carbon fiber brace design on forces across the ankle joint. It is expected that carbon fiber braces can be designed to reduce forces in the ankle. In this study, brace geometry will be varied to determine how these changes influence the forces experienced by ankle cartilage. The purpose of this study is to refine a pre-existing musculoskeletal model and finalize the procedures for inputting multiple data sources into the model to evaluate ankle articular contact stresses.
Status | Completed |
Enrollment | 9 |
Est. completion date | June 25, 2022 |
Est. primary completion date | June 25, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - Between the ages of 18 and 50 - Shoe size between women's 8 and 13.5 or men's 6.5 and 12 - Healthy individuals without a current complaint of lower extremity pain, spine pain, or medical or neuromusculoskeletal disorders that have limited participation in work or exercise in the last 6 months - Full active range of motion of the bilateral lower extremities and spine - Ability to hop without pain - Ability to perform a full squat without pain - Ability to read and write in English and provide written informed consent Exclusion Criteria: - Diagnosed moderate or severe brain injury - Prior lower extremity injury resulting in surgery or limiting function for greater than 6 weeks - Diagnosis of a physical or psychological condition that would preclude testing (e.g. cardiac condition, clotting disorder, pulmonary condition) - Visual or hearing impairment that would interfere with instructions given during testing - Require an assistive device - Wounds to the foot or calf that would prevent CDO use - BMI greater than 35 - Pregnancy - Per participant self-report. Due to the expected small number of pregnant individuals and resulting inability to account for its effect on resulting outcomes, participants will be withdrawn from the study |
Country | Name | City | State |
---|---|---|---|
United States | The University of Iowa | Iowa City | Iowa |
Lead Sponsor | Collaborator |
---|---|
University of Iowa |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Participant Device Preference | The participant will rank order their preference for their standard of care device (if applicable), No Device, CDO-A, CDO-B, CDO-C on a questionnaire. | Baseline | |
Other | Semi-Structured Interview | Semi-structured interviews will also be used to fully capture the patients' perspectives, experience, and opinions associated with the device options they experienced as part of the study. | Baseline | |
Other | Center of Pressure Velocity Timing | Timing of peak center of pressure velocity (percent stance) during gait. | Baseline | |
Other | Center of Pressure Velocity Magnitude | Magnitude of peak center of pressure velocity (m/s) during gait. | Baseline | |
Other | Soleus Muscle Activity (Electromyography) | Electromyography (EMG, % Maximum) of the Soleus during gait. | Baseline | |
Other | Rectus Femoris Muscle Activity (Electromyography) | Electromyography (EMG, % Maximum) of the Rectus Femoris during gait. | Baseline | |
Other | Vastus Medialis Muscle Activity (Electromyography) | Electromyography (EMG, % Maximum) of the Vastus Medialis during gait. | Baseline | |
Other | Medial Gastrocnemius Muscle Activity (Electromyography) | Electromyography (EMG, % Maximum) of the Medial Gastrocnemius during gait. | Baseline | |
Other | Tibialis Anterior Muscle Activity (Electromyography) | Electromyography (EMG, % Maximum) of the Tibialis Anterior during gait. | Baseline | |
Primary | Joint Contact Stress-Time Exposure | Joint contact stress-time exposure (MPA-s/gait cycle) will be estimated using a participant specific musculoskeletal model. The model included surface geometry of each participants tibia and talus. Contact stress -time exposure, measured in MPa-s, was calculated at 13 points across the gait cycle. Higher values indicate greater contact stress-time exposure. | Baseline | |
Secondary | Ankle Range of Motion | Peak dorsiflexion angle (degrees) during gait. | Baseline | |
Secondary | Peak Ankle Moment | Peak ankle moment (Nm/kg) during gait. | Baseline | |
Secondary | Peak Ankle Power | Peak ankle power (W/kg) during gait. | Baseline | |
Secondary | Plantar Force (Total Foot) | Force data (N) collected across the total foot measured between the foot and orthosis during gait. | Baseline | |
Secondary | Plantar Force (Forefoot) | Force data (N) collected across the forefoot (distal 40% of insole) measured between the foot and orthosis during gait. | Baseline | |
Secondary | Plantar Force (Midfoot) | Force data (N) collected across the midfoot (middle 30% of insole) measured between the foot and orthosis during gait. | Baseline | |
Secondary | Plantar Force (Hindfoot) | Force data (N) collected across the hindfoot (proximal 30% of insole) measured between the foot and orthosis during gait. | Baseline | |
Secondary | Four Square Step Test (4SST) | The 4SST (s) is a standardized timed test of balance and agility. | Baseline | |
Secondary | Sit to Stand 5 Times (STS5) | STS5 (s) is a well-established timed measure of lower limb muscle strength and power. Participants are instructed to stand up and sit down 5 times as fast as possible. | Baseline | |
Secondary | Numerical Pain Rating Scale | Pain will be assessed using a standard 11-point numerical pain rating scale, in which 0 = no pain and 10 = worst pain imaginable. | Baseline | |
Secondary | The Orthotics Prosthetics Users' Survey (OPUS) | Satisfaction with device will be assessed using the Orthotics Prosthetics Users' Survey Satisfaction With Device Score. The survey asks users to indicate how much they agree with each statement on a scale from - Strongly Agree (5) to Strongly Disagree (0) with a Don't Know/Not Applicable option. The average score across all questions was calculated and reported, larger scores indicate a better outcome associated with that device. The maximum possible score is a 5 and the minimum possible score is a 0. | Baseline | |
Secondary | Soleus Muscle Force (N) | Peak Soleus muscle forces (N) will be estimated using an Opensim model | Baseline | |
Secondary | Gastrocnemius Muscle Force (N) | Peak Gastrocnemius muscle forces (N) will be estimated using an OpenSim model | Baseline | |
Secondary | Modified Socket Comfort Score (Comfort) | Comfort scores range from 0 = most uncomfortable to 10 = most comfortable. | Baseline | |
Secondary | Modified Socket Comfort Score (Smoothness) | Comfort scores range from 0 = least smooth to 10 = most smooth. | Baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |